Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments

Tissue Antigens

Volumn 50, Issue 3, 1997, Pages 265-276

  Pichuantes, S ^a   Vera, S ^b   Bourdeau, A ^b   Pece, N ^b   Kumar, S ^c   Wayner, E A ^d   Letarte, M ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Endothelial cell; Monoclonal antibody; Recombinant protein; Transforming growth factor beta receptor

Indexed keywords

ENDOGLIN; EPITOPE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIUM; CELL INCLUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FIBROBLAST; GENE MAPPING; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE;

EID: 0030808710     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02870.x     Document Type: Article

References (38)

1. Quackenbush EJ, Letarte M. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 1985: 134: 1276-85.
2. Buhring H-J, Muller CA, Letarte M et al. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 1991: 5: 841-7.
3. Rokhlin OW, Cohen MB, Kubagawa H, Letarte M, Cooper MD. Differential expression of endoglin in fetal and adult hematopoietic cells in human bone marrow. J Immunol 1995: 154: 4456-65.
4. Robledo MM, Hidalgo A, Lastres P et al. Characterization of TGF-β1-binding proteins in human bone marrow stromal cells. Br J Haematol 1996: 93: 507-14.
5. Zhang HW, Shaw ARE, Mak A, Letarte M. Endoglin is a component of the TGF-β receptor complex of human pre-B leukemic cells. J Immunol 1996: 156: 565-73.
6. Yamashita H, Ichijo H, Grimsby S, Morén A, ten Dijke P, Miyazono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J Biol Chem 1994: 269: 1995-2001.
7. Lastres P, Bellon T, Cabanas C et al. Regulated expression on human macrophages of endoglin, an RGD containing surface antigen. Eur J Immunol 1992: 22: 393-7.
8. O'Connell PJ, McKenzie A, Fisicaro N, Rockman SP, Pearse MJ, d'Apice AJF. Endoglin: a 180-kD endothelial and macrophage restricted differentiation molecule. Clin Exp Immunol 1992: 90: 154-9.
9. Lastres P, Letamendia A, Zhang H et al. Endoglin modulates cellular responses to TGF-β1. J Cell Biol 1996: 133: 1109-21.
10. Cheifetz S, Bellón T, Calés C et al. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 1992: 267: 19027-30.
11. Lastres P, Almendro N, Bellon T, Lopes-Guerrero JA, Eritja R, Bernabeu C. Functional regulation of platelet endothelial cell adhesion molecule-1 by TGF-β1 in promonocytic U-937 cells. J Immunol 1994: 153: 4206-18.
12. Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 1988: 141: 1925-33.
13. Letarte M, Greaves A, Vera S CD105 (endoglin) cluster report. In Schlossman SF, Boumsell L, Gilks W et al., ed. Leukocyte typing. V. White cell differentiation antigens. Oxford: Oxford University Press, 1995: 1756-9.
14. McAllister KA, Grogg KM, Johnson DW et al. Endoglin, a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet 1994: 8: 345-51.
15. Guttmacher AE, Marchuk DA, White RIJ. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995: 333: 918-24.
16. McAllister KA, Baldwin MA, Thukkani AK et al. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia tupe 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995: 4: 1983-5.
17. Yamaguchi H, Azuma H, Shigekiyo T, Inoue H. A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia. Thromb Haemostasia 1997: 77: 243-7.
18. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990: 265: 8361-4.
19. Gougos A, St. Jacques S, Greaves A et al. Identification of distinct epitopes of endoglin, an RGD containing-glycoprotein of endothelial cells, leukemic cells and syncytiotrophoblasts. Int Immunol 1992: 4: 83-92.
20. Wang JM, Kumar S, Pye D, Van Agthoven AJ, Krupinski J, Hunter RD. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 1993: 54: 363-370.
21. Westphal JR, Willems HW, Schalkwijk CJM, Ruiter DJ, De Waal RMW. A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. J Invest Dermatol 1993: 100: 27-34.
22. Thorpe PE, Burrows FJ. Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treatment 1995: 36: 237-51.
23. Burrows FJ, Derbyshire EJ, Tazzari PL et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1995: 1: 1623-34.
24. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG. Identification and characterization of the T lymphocyte adhesion receptor for an alternate cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989: 109: 1321-30.
25. Letarte M, Bourdeau A, Vera S et al. EC2 CD105 Workshop Panel report. In: Leukocyte typing VI. London: Garland Publishing (in press).
26. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963: 17: 299-313.
27. Bellón T, Corbi A, Lastres P et al. Identification and expression of two forms of the human transforming growth factor-β binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993: 23: 2340-45.
28. Sadler JR, Tecklenburg M, Betz JL. Plasmid containing many tandem copies of a synthetic lactose operator. Gene 1980: 8: 279-300.
29. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990: 158: 60-89.
30. Higuchi R Recombinant PCR. In Innis MA, Gelfand DH, Sninsky JJ, White TJ, ed. PCR protocols. A guide to methods and applications. San Diego: Academic Press, 1990: 177-83.
31. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
32. Letarte M, Teh H-S, Meghji G. Increased expression of la and Thy-1 antigens on mitogen-activated murine spleen lymphocytes. J Immunol 1980: 125: 370-7.
33. St-Jacques S, Cymerman U, Pece N, Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells. Endocrinology 1994: 134: 2645-57.
34. Ge AZ, Butcher EC. Cloning and expression of a cDNA encoding mouse endoglin, an endothelial TGF-β ligand. Gene 1994: 138: 201-6.
35. Nguyen LH, Jensen DB, Burgess RR. Overproduction and purification of σ32, the Escherichia coli heat shock transcription factor. Protein Expression Purification 1994: 4: 425-33.
36. Wang J-M, Kumar S, van Agthoven A, Kumar P, Pye D, Hunter RD. Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. Int J Cancer 1995: 62: 791-6.
37. Westphal JR, Willems HW, Schalkwijk CJM, Ruiter DJ, de Waal RMW. Characteristics and possible function of endoglin, a TGF-β binding protein. Behring Inst Mitteil 1993: 92: 15-22.
38. Schwartz BR, Harlan JM Endothelial cell antigens: section report. In Schlossman SF, Boumsell L, Gilks W et al., ed. Leukocyte typing. V. White cell differentiation antigens. Oxford: Oxford University Press, 1995: 1745-56.